Biovian present in strength at BIO-Europe Frankfurt
Press Release | Biovian Ltd
SEPTEMBER 22, 2014
Turku, Finland: – Biopharmaceutical CMO Biovian is to field a strong team at November’s BIO-Europe biotechnology partnering conference in Germany.
The Finnish-based manufacturer’s presence in Frankfurt will be led by its CEO, Dr. Knut Ringbom, and Director of Business Development and Projects, Mr. Antti Nieminen. Both men will be available for one-to-one meetings and to share news of latest developments in Biovian’s distinctive “gene to finished vial” end-to-end GMP service.
They will also be available via the conference’s web-based partnering ONE system to set up in-depth discussions on biopharma research or manufacturing projects that require the Finnish contract manufacturer’s extensive range of cGMP manufacturing and development services.
Online partnering opportunities
“We have attended Bio-Europe events many times before, most recently in Turin during the spring,” said Antti Nieminen.
“This event is a very good fit for our company and we usually meet many of our existing customers as well as potential new partners,” he explained.
“Once again, we’re looking forward to arranging productive meetings with existing and prospective partners, showing them how Biovian has become a true ‘one stop shop’ CMO for GMP manufacture of biopharmaceuticals,” said Mr. Nieminen.
“On our stand at Both 38 and over the online partnering system, we will be available to provide in-depth information on our biopharmaceutical manufacturing capabilities and our latest developments,” he added.
Biovian Ltd. is a one-stop-shop Contract Manufacturing Organization (CMO) specializing in full-process development and manufacture that extends ‘from gene to finished vial’.
Biovian offers Good Manufacturing Practice compliant (cGMP) services from its 2,300 square meter facilities in Turku, Finland, that are EMA and FDA certified for production of investigational and commercial products.
The CMO has more than a decade’s successful track record in pharmaceutical contract manufacturing ranging over a wide variety of different biopharmaceutical projects. Biovian GMP services include microbial fermentation, mammalian cell culture, viral vector production, protein purification, formulation, aseptic fill & finish, analytical quality control, stability studies and master cell banking. It also offers labeling, packaging, storage and QP release services.
Biovian also provides development services that cover cell line, process and analysis.
About BIO-Europe Autumn 2014
The BIO-Europe Autumn® Conference is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe®, aiming to provide life science companies with further high caliber partnering opportunities.
The 2014 Bio-Europe Spring event is being held on November 7-9 t the Portalhaus Messe exhibition center in Frankfurt-am-Main.
The BIO-Europe partnering conferences have been running since 2006 and consistently attract top international executives from established and emerging pharma and biotech companies, along with academic researchers and private investors including venture capital and private equity and organizations developing companion diagnostics.
More than 3,000 people attended the 2013 Bio Europe Autumn event in Frankfurt, representing some 1,800 companies and organizations from 56 countries, along with 95 exhibitors. The 2013 event also featured more than 180 presentations and 18 workshops or panels.
The event is organised by EBD Group, whose sophisticated web-based partnering ONE system was last year used to facilitate almost 18,000 one-to-one meetings, with some 3,600 licensing opportunities posted.
More information at: http://www.ebdgroup.com/bioeurope/index.php
Name: Antti Nieminen, Director, Business Development and Projects, Biovian Ltd.
Tel: +358 40 5021332